This webinar was recorded on Wednesday, 13th August 2025.

This webinar is a discussion with Andrew Aijian and Hannah Glazier, co-authors of DeciBio’s newly released Pharma R&D Services Market Report (2024–2029). This session is designed for executives and strategists at CROs, CDx developers, lab services providers, and bioinformatics companies looking to deepen their understanding of the pharma outsourcing ecosystem.

‍

We’ll explore:

• How macroeconomic and geopolitical shifts are shaping pharma outsourcing strategies

• Which therapeutic modalities and service areas are driving market growth

• Where large CROs have maintained dominance—and where niche players are gaining ground

• What pharma customers are prioritizing when choosing service partners

‍

Following the market overview, Deborah Phippard, PhD, will join Andrew and Hannah for a fireside chat. Dr. Phippard will share her perspective on the current and future state of pharma services, drawing on her experience leading biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the NIH. This interactive discussion will explore how her insights align with—or challenge—DeciBio’s market findings.

‍

Check out our webinar to hear key insights from DeciBio’s research, informed by 35 stakeholder interviews and robust financial modeling. This is a must-watch for anyone looking to better position their organization for the future of pharma services.

‍

Speakers:

• Deborah Phippard Ph.D., Chief Science Office at Precision for Medicine
• Andrew Aijian, Ph.D., Partner at DeciBio Consulting
• Hannah Glazier, Product Manager at DeciBio Consulting

Moderator:

• Megan Nacar, VP of Commercial at DeciBio Consulting

‍

View the webinar recording:

‍

‍

Our report provides a comprehensive overview of the global Pharma R&D Services market from 2024 to 2029. The market is defined as revenue generated from outsourced research and development services commissioned by pharmaceutical companies, including discovery, preclinical, clinical, quality control, diagnostics (CDx/Dx), and bioinformatics services.

DeciBio's Pharma R&D Services Market Report, First Edition: 2024-2029 is now available for purchase. Download a sample of the report here.

‍